[HTML][HTML] Editor's Choice--European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb …
J Nordanstig, CA Behrendt, I Baumgartner… - European Journal of …, 2024 - Elsevier
BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …
TASC II document on the management of peripheral arterial disease
DJ Adam, AW Bradbury - … Journal of Vascular and Endovascular Surgery, 2007 - ejves.com
The original TransAtlantic InterSociety Consensus (TASC) on the Management of Peripheral
Arterial Disease (PAD) published in 2000 was the first international consensus on the …
Arterial Disease (PAD) published in 2000 was the first international consensus on the …
Paclitaxel-coated balloon in infrapopliteal arteries: 12-month results from the BIOLUX P-II randomized trial (BIOTRONIK'S-first in man study of the Passeo-18 LUX drug …
T Zeller, U Beschorner, E Pilger, M Bosiers… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives: The aim of BIOLUX P-II (BIOTRONIK'S–First in Man study of the Passeo-18 LUX
drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in …
drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in …
A prospective, multi‐center study of the chocolate balloon in femoropopliteal peripheral artery disease: The C hocolate BAR registry
JA Mustapha, A Lansky, M Shishehbor… - Catheterization and …, 2018 - Wiley Online Library
The Chocolate BAR study is a prospective multicenter post‐market registry designed to
evaluate the safety and performance of the Chocolate percutaneous transluminal …
evaluate the safety and performance of the Chocolate percutaneous transluminal …
[HTML][HTML] The next 10 years in the management of peripheral artery disease: perspectives from the 'PAD 2009'Conference
OBJECTIVES: To briefly inform on the conclusions from a conference on the next 10 years in
the management of peripheral artery disease (PAD). DESIGN OF THE CONFERENCE …
the management of peripheral artery disease (PAD). DESIGN OF THE CONFERENCE …
Why do health systems not fund supervised exercise programmes for intermittent claudication?
MA Popplewell, AW Bradbury - European journal of vascular and …, 2014 - ejves.com
In August 2012 the UK National Institute for Heath and Care Excellence (NICE) published
Clinical Guideline (CG) 147 on Peripheral Arterial Disease (PAD). 1 The recommendations …
Clinical Guideline (CG) 147 on Peripheral Arterial Disease (PAD). 1 The recommendations …
[HTML][HTML] Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and …
Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an
increasing amount of resources in the United States health care system. Overall rates of …
increasing amount of resources in the United States health care system. Overall rates of …
Management of patients after endovascular interventions for peripheral artery disease
P Sobieszczyk, A Eisenhauer - Circulation, 2013 - Am Heart Assoc
Endovascular therapy to relieve intermittent claudication or critical limb ischemia in patients
with lowerextremity peripheral artery disease is now firmly established as an alternative to …
with lowerextremity peripheral artery disease is now firmly established as an alternative to …
[HTML][HTML] Management of chronic peripheral artery disease patients with indication for endovascular revascularization
With an increasing global burden of patients with chronic peripheral artery disease (PAD)
the safe and effective provision of lower limb revascularisation is a growing medical need …
the safe and effective provision of lower limb revascularisation is a growing medical need …
Peripheral arterial disease: diagnosis and management in general practice
TB Au, J Golledge, PJ Walker, K Haigh… - Australian family …, 2013 - search.informit.org
Background: Peripheral arterial disease (PAD) is a manifestation of systemic
atherosclerosis. It affects 10-15% of the general population, and is often asymptomatic; …
atherosclerosis. It affects 10-15% of the general population, and is often asymptomatic; …